T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$883M |
| 2 |
AbbVie
ABBV
|
+$660M |
| 3 |
Intuit
INTU
|
+$528M |
| 4 |
Xcel Energy
XEL
|
+$466M |
| 5 |
Exelon
EXC
|
+$430M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$1.2B |
| 2 |
TE Connectivity
TEL
|
+$607M |
| 3 |
Equifax
EFX
|
+$347M |
| 4 |
KLA
KLAC
|
+$317M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.65% |
| 2 | Healthcare | 22.76% |
| 3 | Financials | 12.37% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Industrials | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Opendoor
OPEN
$3.38B
| $19.1M | 0.01% |
11,238,810
+1,301,848
| +13% | +$2.14M |
|
|
VTYX
477
DELISTED
Ventyx Biosciences
VTYX
| $18.9M | 0.01% |
+564,636
| New | +$22M |
|
|
RPTX
478
DELISTED
Repare Therapeutics
RPTX
| $18.8M | 0.01% |
1,912,351
-5,675
| -0.3% | -$65.1K |
|
|
DAY
479
DELISTED
Dayforce
DAY
| $18.7M | 0.01% |
255,441
-5,675
| -2% | -$403K |
|
480
Nkarta
NKTX
$173M
| $18.4M | 0.01% |
5,177,788
+428,687
| +9% | +$2.03M |
|
481
RGC Resources
RGCO
$222M
| $18.1M | 0.01% |
781,180
-10,975
| -1% | -$259K |
|
482
Hercules Capital
HTGC
$3.13B
| $18.1M | 0.01% |
1,404,876
+23,126
| +2% | +$323K |
|
483
Middleby
MIDD
$5.37B
| $17.3M | 0.01% |
118,285
+1,907
| +2% | +$283K |
|
484
Pool Corp
POOL
$7.28B
| $17.2M | 0.01% |
50,156
-21
| -0% | -$7.45K |
|
485
Badger Meter
BMI
$3.85B
| $16.9M | 0.01% |
138,644
+2,230
| +2% | +$261K |
|
486
Dutch Bros
BROS
$9.2B
| $16.5M | 0.01% |
520,616
-7,969
| -2% | -$270K |
|
487
Kimbell Royalty Partners
KRP
$1.52B
| $16.2M | 0.01% |
1,065,307
-1,370,357
| -56% | -$21.5M |
|
488
Red Robin
RRGB
$191M
| $16.1M | 0.01% |
1,122,744
-1,576
| -0.1% | -$16K |
|
489
Advantage Solutions
ADV
$420M
| $15.8M | 0.01% |
400,726
+26,425
| +7% | +$1.49M |
|
490
Insteel Industries
IIIN
$636M
| $15.7M | 0.01% |
563,698
| – | – |
|
491
Crinetics Pharmaceuticals
CRNX
$8.97B
| $14.9M | 0.01% |
+929,369
| New | +$17.2M |
|
492
Denali Therapeutics
DNLI
$4.05B
| $14.9M | 0.01% |
647,013
+13,655
| +2% | +$376K |
|
|
GBIO
493
DELISTED
Generation Bio
GBIO
| $14.5M | 0.01% |
338,096
-19,680
| -6% | -$952K |
|
494
Structure Therapeutics
GPCR
$3.78B
| $14.2M | 0.01% |
+598,108
| New | +$14.1M |
|
|
UMH
495
UMH Properties
UMH
$1.42B
| $14M | 0.01% |
946,826
+109,291
| +13% | +$1.8M |
|
|
XM
496
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $13.6M | 0.01% |
764,439
-351,567
| -32% | -$5.37M |
|
497
REX American Resources
REX
$1.44B
| $13.6M | 0.01% |
952,312
-68,454
| -7% | -$1.08M |
|
498
Arvinas
ARVN
$587M
| $13.4M | 0.01% |
492,180
-660,613
| -57% | -$20.9M |
|
499
Monte Rosa Therapeutics
GLUE
$1.38B
| $13.4M | 0.01% |
1,717,065
-217,474
| -11% | -$1.51M |
|
500
HubSpot
HUBS
$10.8B
| $12.6M | 0.01% |
29,300
+445
| +2% | +$162K |
|
Similar funds
T. Rowe Price Investment Management's Q1 2023 Portfolio in Review
As of Q1 2023, T. Rowe Price Investment Management held 578 positions worth $139B, up 7% from $130B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Investment Management's Q1 2023 filing shows 37 new, 240 increased, 253 reduced and 34 closed positions. Its largest new stake was Intuit: 1,286,488 shares worth $574M. The largest sale was GE Aerospace, an estimated $1.2B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q1 2023 buy was Intuit: 1,286,488 shares worth $574M.
- T. Rowe Price Investment Management added most to UnitedHealth in Q1 2023, an estimated $883M increase.
- T. Rowe Price Investment Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $1.2B.
- T. Rowe Price Investment Management fully exited Public Service Enterprise Group in Q1 2023, selling an estimated $276M.
- T. Rowe Price Investment Management's ten largest holdings make up 17% of its $139B portfolio in Q1 2023.
- T. Rowe Price Investment Management opened 37 new positions and closed 34 in Q1 2023.
- T. Rowe Price Investment Management's portfolio value rose 7% quarter-over-quarter to $139B.
Based on T. Rowe Price Investment Management's 13F filing for Q1 2023, filed 15 May 2023.